Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Investor Meet with Premji Invest and Alchemy Capital on 15-Feb-202109-02-2021
09-02-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Details of Investor Conferences the Company plan to attend during the month of February 2021: Edelweiss India Annual e-Conference 2021 on Feb 9, 2021 and IIFL Securities - Global Investor Conference on Feb 25, 202106-02-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Video/Tele - Conference - One on One with Nomura Asset Management on 17th February 202105-02-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Tele/Video Conference - One on One meeting with Neuberger Berman Group LLC on 12-Feb-202104-02-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Investor Meet with Nippon India Mutual Fund and Pictet Asset Management UK Ltd. on 10-Feb-2021 and 11-Feb-202102-02-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Tele/Video Conference - One on One meeting with Capital Research Global Investors on 10-Feb-202102-02-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Tele/Video Conference - One on One meeting with Government Of Singapore on 3-Feb-202129-01-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Tele/Video Conference - One on One with Goldman Sachs India SPL on 4-Feb-202128-01-2021
Gland Pharma Q3: Strong and clean play on global generic injectables; accumulate
We believe dominance of profit/royalty-sharing aspect in the business model distinguishes Gland Pharma from other contract manufacturers25-01-2021
Earnings Call for Q3FY21 of Gland Pharma
Conference Call with Gland Pharma Management and Analysts on Q3FY21 Performance and Outlook. Listen to the full earnings transcript.23-01-2021